AICAR 50mg Vial

Futureproof Peptides

AICAR 50mg Vial by Futureproof Peptides is a research product containing 50mg of AICAR, supplied in vial format for laboratory and scientific research purposes. Also known in scientific literature as AICA ribonucleoside or acadesine, this compound has been widely studied in research involving cellular energy sensing, metabolism and AMP-activated protein kinase (AMPK) pathways. This product is intended for research purposes only and is not presented as a medicine, treatment or product for human consumption.

Product Overview

The AICAR 50mg Vial provides researchers with a clearly identified quantity of AICAR in a convenient vial format. Futureproof Peptides is the stated brand for this product, while the product page should clearly communicate the compound, quantity and research-use designation.

AICAR is commonly discussed in scientific literature in connection with AMPK-related research. It is important, however, to interpret this research carefully. A scientific review indexed by PubMed notes that AICAr has been widely used in studies of AMPK biology while also highlighting that the compound can produce AMPK-independent effects. This makes careful experimental design and interpretation important when evaluating research involving the compound. PubMed

For researchers purchasing AICAR, clear product identification and accurate research-use labelling are important considerations. The AICAR 50mg Vial is presented as a research product, allowing laboratories and qualified researchers to evaluate its suitability for their own scientific work.

Why Choose AICAR 50mg Vial?

Selecting a research compound requires more than simply choosing a product name. Researchers should consider whether the product information clearly identifies the compound, quantity and intended research status.

This Futureproof Peptides product offers a straightforward 50mg vial format with the compound and quantity clearly reflected in the product name. The format may be relevant for researchers organising compound inventories or comparing products for laboratory research.

No unsupported claims about purity, testing, certifications, manufacturing standards or biological performance are made here. Where additional documentation is available from the supplier, researchers should review it directly before making a purchasing decision.

Clear product specifications and appropriate labelling can help researchers distinguish research products from medicinal products. In the UK, information on authorised medicines and their official product documentation can be accessed through the MHRA Products database. Research-use products should not be confused with authorised medicines. products.mhra.gov.uk

Research Information

AICAR-related terminology can require careful interpretation. Scientific literature commonly refers to the administered nucleoside as AICAr or AICA ribonucleoside, while “AICAR” can also refer to a related phosphorylated compound involved in purine biosynthesis. Product and scientific naming may therefore vary, making it important for researchers to review compound identity and supporting documentation carefully. PubMed Central (PMC)

AICAr has been widely used as a pharmacological tool in studies investigating AMPK signalling and cellular metabolism. Research literature also describes effects that are not solely explained by AMPK activation, which means findings should not automatically be attributed to a single pathway. The systematic scientific review available through PubMed’s AICAr research record provides useful background on both AMPK-dependent and AMPK-independent research contexts. PubMed

Researchers may encounter AICAR-related studies across areas including cellular metabolism, energy-sensing pathways, nucleotide biology and experimental models of cellular function. These research contexts should be understood as areas of scientific investigation, not as evidence of proven benefits or outcomes in humans.

The published literature is useful for understanding experimental context, but individual findings can depend on the model, methodology and conditions used. Researchers should therefore evaluate original scientific literature and apply appropriate controls when designing studies.

Quality & Trust

Trust in a research product begins with transparent information. For the AICAR 50mg Vial, the verified information provided here is limited to the product name, brand, 50mg quantity, vial format and research-use positioning.

No claims are made regarding independent testing, batch-specific analysis, Certificates of Analysis, purity percentages, pharmaceutical status or manufacturing certifications unless such information is separately provided and can be verified.

Researchers are encouraged to review available supplier documentation and contact the retailer directly with questions regarding product information, documentation or ordering support. Clear specifications and transparent communication are important factors when evaluating any research compound supplier.

Buying With Confidence

When purchasing research compounds in the UK, customers should carefully review product information before ordering. Useful factors to consider include:

• Clear identification of the compound
• Transparent quantity and product format
• Appropriate research-use labelling
• Available product documentation
• Clear customer support information
• Secure checkout procedures
• Transparent shipping information

Customers should also understand the distinction between research products and authorised medicinal products. The UK MHRA medicines information service provides official information relating to authorised medicines and their documentation. This helps provide useful regulatory context when evaluating how a product is presented.

Important Research-Use Notice

AICAR 50mg Vial is intended for research purposes only. It is not presented as a medicine, treatment or therapeutic product, and this product description does not provide guidance for human consumption or administration. Scientific research involving AICAR should not be interpreted as proof of medical or physiological benefits.